Video wird geladen...

Video konnte nicht geladen werden

Beim Laden dieses Videos ist ein Problem aufgetreten. Dies könnte an einem vorübergehenden Netzwerkproblem liegen oder das Video ist möglicherweise nicht verfügbar.

The FDA’s recent recommendations on peptides are a significant setback for new and existing companies being built around the expectation that they will be able to sell compounded peptides. That’s because the 503A Bulks List is basically a pathway that lets compounding pharmacies use certain bulk drug substances to... show more

TBPN

1,171,414 subscribers

48,450 Aufrufe • vor 2 Monaten •via X (Twitter)

Anya Rossi• Live Now

Private livecam show

0 Kommentare

Keine Kommentare verfügbar

Kommentare vom Original-Post werden hier angezeigt

Ähnliche Videos

$HIMS $ENHA 🚨 MAX MARTIN & Christian Angermayer SAY ENHANCED WILL BE 'READY TO GO' AS SOON AS THE FDA MOVES PEPTIDES TO CATEGORY 1 "The goal is to be ready immediately after, yes." "Because think about it like this: What actually happens is that when 503A pharmacies are again able to compound those peptides, those are the pharmacies that we are already working with, that we already have the delivery and operational chain set up." "The doctors that are going to be able to prescribe those [peptides] are going to be the same doctors we are already working with." "And so from an infrastructure perspective, not much changes." "So from an infrastructure perspective, we are ready to go as soon as that change happens."

$HIMS $ENHA 🚨 MAX MARTIN & Christian Angermayer SAY ENHANCED WILL BE 'READY TO GO' AS SOON AS THE FDA MOVES PEPTIDES TO CATEGORY 1 "The goal is to be ready immediately after, yes." "Because think about it like this: What actually happens is that when 503A pharmacies are again able to compound those peptides, those are the pharmacies that we are already working with, that we already have the delivery and operational chain set up." "The doctors that are going to be able to prescribe those [peptides] are going to be the same doctors we are already working with." "And so from an infrastructure perspective, not much changes." "So from an infrastructure perspective, we are ready to go as soon as that change happens."

Hims House

28,393 Aufrufe • vor 4 Monaten

RFK Jr. says the FDA’s war on peptides and other alternative medicines is over. “We’re gonna end the war at the FDA against alternative medicine.” “The war on stem cells, the war on chelating drugs, the war on peptides, the war on vitamins.” “The FDA has a job to do the science on these kind of issues.” “And then tell the public what they've learned from the science.” “But not tell people and not tell physicians what they can and cannot prescribe.”

RFK Jr. says the FDA’s war on peptides and other alternative medicines is over. “We’re gonna end the war at the FDA against alternative medicine.” “The war on stem cells, the war on chelating drugs, the war on peptides, the war on vitamins.” “The FDA has a job to do the science on these kind of issues.” “And then tell the public what they've learned from the science.” “But not tell people and not tell physicians what they can and cannot prescribe.”

MAHA Action

226,966 Aufrufe • vor 1 Monat

Imagine going to the doctors and they recommend Peptides or vitamins ? 🚨 RFK Jr is ending the FDA war against Alternative Medicines — Stem Cells, Chelating Drugs, Peptides, Vitamins & Minerals 🙌 “The FDA’s job will be to do the science and then tell the public what they’ve learned from the science, but not tell physicians what they’ve can and cannot prescribe… What the Government is giving us access to right now is not making us healthier.” Clip Full Show

Imagine going to the doctors and they recommend Peptides or vitamins ? 🚨 RFK Jr is ending the FDA war against Alternative Medicines — Stem Cells, Chelating Drugs, Peptides, Vitamins & Minerals 🙌 “The FDA’s job will be to do the science and then tell the public what they’ve learned from the science, but not tell physicians what they’ve can and cannot prescribe… What the Government is giving us access to right now is not making us healthier.” Clip Full Show

MJTruthUltra

24,900 Aufrufe • vor 1 Jahr

$HIMS $LLY $NVO 🚨 BREAKING: RFK SAYS THE FDA IS LOOKING TO REMOVE 14 PEPTIDES FROM THE CATEGORY 2 LIST -- WHICH CURRENTLY BANS THEM FROM BEING COMPOUNDED SAYS ACTION LIKELY COMING "WITHIN A COUPLE WEEKS" h/t On The Pen™ - incredible find

$HIMS $LLY $NVO 🚨 BREAKING: RFK SAYS THE FDA IS LOOKING TO REMOVE 14 PEPTIDES FROM THE CATEGORY 2 LIST -- WHICH CURRENTLY BANS THEM FROM BEING COMPOUNDED SAYS ACTION LIKELY COMING "WITHIN A COUPLE WEEKS" h/t On The Pen™ - incredible find

Hims House

185,852 Aufrufe • vor 6 Monaten

“People are getting these on the gray market and they're treating themselves at home with a needle in their bathroom, which is bananas.” Jillian Michaels says RFK Jr.’s move on peptides will crack down on dangerous gray-market use. “We’re talking about 12 peptides because these are the most heavily researched.” “By opening this up, you’re allowing proper compounding pharmacies to make safe peptides.” “So you don’t have things like heavy metals and hormones and all kinds of dangerous garbage in them.” Jillian Michaels

“People are getting these on the gray market and they're treating themselves at home with a needle in their bathroom, which is bananas.” Jillian Michaels says RFK Jr.’s move on peptides will crack down on dangerous gray-market use. “We’re talking about 12 peptides because these are the most heavily researched.” “By opening this up, you’re allowing proper compounding pharmacies to make safe peptides.” “So you don’t have things like heavy metals and hormones and all kinds of dangerous garbage in them.” Jillian Michaels

MAHA Action

22,576 Aufrufe • vor 4 Monaten

$HIMS THE CAT IS OUT OF THE BAG WITH PEPTIDES Jonathan: "There is no going back to 2010. These have taken over the cultural consciousness and are here to stay... What happens, though, if the 7 peptides are not approved?" Jesse Morse, M.D.: "So here's the problem. The demand is there. Right now, the supply is the problem, and part of that supply is purity and safety." "Millions of people are taking peptides every day in the United States." "Less than 5% of them, if I were to guess, are being compounded by American pharmacies." "That means 95% of the peptides that are not GLPs are being ordered from some random website or picked up at a bodega in New York." "The FDA has to see this, and they have to say, 'Hey, I understand this is not ideal, and we don't have 10 years of beautiful data. But unfortunately, this is the situation we're in.' "

$HIMS THE CAT IS OUT OF THE BAG WITH PEPTIDES Jonathan: "There is no going back to 2010. These have taken over the cultural consciousness and are here to stay... What happens, though, if the 7 peptides are not approved?" Jesse Morse, M.D.: "So here's the problem. The demand is there. Right now, the supply is the problem, and part of that supply is purity and safety." "Millions of people are taking peptides every day in the United States." "Less than 5% of them, if I were to guess, are being compounded by American pharmacies." "That means 95% of the peptides that are not GLPs are being ordered from some random website or picked up at a bodega in New York." "The FDA has to see this, and they have to say, 'Hey, I understand this is not ideal, and we don't have 10 years of beautiful data. But unfortunately, this is the situation we're in.' "

Hims House

28,542 Aufrufe • vor 1 Monat

🚨 ARE YOU ACCIDENTALLY SELF-VACCINATING WITH PEPTIDES? — HEALTH INFLUENCERS ARE FREAKING OUT People are asking a disturbing question: Are we accidentally self-vaccinating while using peptides? The claim is that Big Pharma (including Pfizer) is putting COVID and other vaccines into peptides. Who uses peptides? Gym bros, health conscious people, and those who skipped the original shots. So how does Big Pharma reach them? By selling them peptides. Health influencers are pushing peptides hard, while allegedly self-vaccinating and calling it a "new discovery." And yes... many of these peptide companies have ties to vaccine giants and Bill Gates. They couldn’t force the shot… so they made you inject it yourself. Do you believe it and would you still use peptides knowing this?

🚨 ARE YOU ACCIDENTALLY SELF-VACCINATING WITH PEPTIDES? — HEALTH INFLUENCERS ARE FREAKING OUT People are asking a disturbing question: Are we accidentally self-vaccinating while using peptides? The claim is that Big Pharma (including Pfizer) is putting COVID and other vaccines into peptides. Who uses peptides? Gym bros, health conscious people, and those who skipped the original shots. So how does Big Pharma reach them? By selling them peptides. Health influencers are pushing peptides hard, while allegedly self-vaccinating and calling it a "new discovery." And yes... many of these peptide companies have ties to vaccine giants and Bill Gates. They couldn’t force the shot… so they made you inject it yourself. Do you believe it and would you still use peptides knowing this?

HustleBitch

293,023 Aufrufe • vor 1 Monat

today, we're announcing our most long-awaited offering – Superpower Peptides. 1 in 5 Americans have already tried a GLP1, but the wave is only beginning. for too long, people seeking access to new peptides have been left with two options: go without, or turn to unregulated sources that put their health at risk. that's beginning to change. and we've been building. introducing Superpower Peptides: • Pure. Third-party tested. • Rigorously sourced • Backed by science as the FDA moves to restore regulated access to 12 key peptides (like BPC 157), we are ready. existing members get early access today. peptides will be one of the biggest revolutions in human health and one of the fastest growing consumer markets next to AI. you can reserve your username on our waitlist here: 👉 superpower . com / peptides __ peptides, by Superpower. a new era of health is coming.

today, we're announcing our most long-awaited offering – Superpower Peptides. 1 in 5 Americans have already tried a GLP1, but the wave is only beginning. for too long, people seeking access to new peptides have been left with two options: go without, or turn to unregulated sources that put their health at risk. that's beginning to change. and we've been building. introducing Superpower Peptides: • Pure. Third-party tested. • Rigorously sourced • Backed by science as the FDA moves to restore regulated access to 12 key peptides (like BPC 157), we are ready. existing members get early access today. peptides will be one of the biggest revolutions in human health and one of the fastest growing consumer markets next to AI. you can reserve your username on our waitlist here: 👉 superpower . com / peptides __ peptides, by Superpower. a new era of health is coming.

jacob peters

11,001 Aufrufe • vor 4 Monaten

Okay this is disturbing. You know all those Chinese companies that were sending the fentanyl precursors to Mexico to poison our children? Those same companies have now pivoted and are sending peptides into the American market. Many of these are not FDA approved! I think we need to put the brakes on this and get track of who's doing what to whom. Peptides are the wild west right now. Folks are taking a lot of things that they don't really know what's in them. What's your take on this?

Okay this is disturbing. You know all those Chinese companies that were sending the fentanyl precursors to Mexico to poison our children? Those same companies have now pivoted and are sending peptides into the American market. Many of these are not FDA approved! I think we need to put the brakes on this and get track of who's doing what to whom. Peptides are the wild west right now. Folks are taking a lot of things that they don't really know what's in them. What's your take on this?

Bill Mitchell

12,574 Aufrufe • vor 1 Monat

Superpower co-founder Max Marchione describes how he went from being a peptide skeptic to a peptide believer: "When I was first introduced to peptides, one of the most esteemed doctors in the US said to me: 'You take so many supplements. Have you explored peptides? Because I think they're a really interesting modality with a few decades of clinical use.'" "When he said that to me, I was like, 'No way. This is BS. I'm not injecting myself with something. That's weird.'" "So what I did is, I went around to around 20 different doctors whose opinions I respect, and I asked them about peptides. Normally when you ask these doctors about anything — you ask about red meat, spinach, [etc.] — they're all divided." "With peptides, all of them except one said 'These are really interesting. I have used these in my patients. I believe endogenous molecules — peptides that exist in our body — are going to be the future of medicine.'" "And those doctors have the incentive not to be wrong. If they're wrong, they could go to jail. If they're wrong, they can have their license stripped. If they're wrong, patients don't come back to them. They have the maximum incentive. And for 10 to 20 years, they still give [peptides] to their patients. And their patients say 'My life changed.'" "You might say it's placebo. My statement is that the patient says their life changes, and the doctor sees that."

Superpower co-founder Max Marchione describes how he went from being a peptide skeptic to a peptide believer: "When I was first introduced to peptides, one of the most esteemed doctors in the US said to me: 'You take so many supplements. Have you explored peptides? Because I think they're a really interesting modality with a few decades of clinical use.'" "When he said that to me, I was like, 'No way. This is BS. I'm not injecting myself with something. That's weird.'" "So what I did is, I went around to around 20 different doctors whose opinions I respect, and I asked them about peptides. Normally when you ask these doctors about anything — you ask about red meat, spinach, [etc.] — they're all divided." "With peptides, all of them except one said 'These are really interesting. I have used these in my patients. I believe endogenous molecules — peptides that exist in our body — are going to be the future of medicine.'" "And those doctors have the incentive not to be wrong. If they're wrong, they could go to jail. If they're wrong, they can have their license stripped. If they're wrong, patients don't come back to them. They have the maximum incentive. And for 10 to 20 years, they still give [peptides] to their patients. And their patients say 'My life changed.'" "You might say it's placebo. My statement is that the patient says their life changes, and the doctor sees that."

TBPN

37,426 Aufrufe • vor 5 Monaten

$HIMS 🚨 NEEDHAM'S RYAN MACDONALD SAYS HIS "BASE CASE" IS THAT PEPTIDES WILL BE APPROVED Jonathan Stern: "I have seen a ton of alarmist tweets saying, 'RIP to the peptide bros', essentially. And what you're saying, Ryan, is that it's really not that simple." "We have a process here. We're going to go to PCAC. PCAC is going to make a recommendation to the FDA. But after the PCAC recommendation, the FDA gets to decide. Is that right?" Ryan MacDonald: "Yeah. That's correct... PCAC can make its recommendation and then from there it goes to FDA to make a final decision." "And based on the research that I've done... the final decision goes to the top, goes to the head of the FDA [RFK Jr.]." "It would be surprising to me if there wasn't some sort of involvement from RFK given how vocal he has been." "It's the FDA leadership's domain to make the final decision on this."

$HIMS 🚨 NEEDHAM'S RYAN MACDONALD SAYS HIS "BASE CASE" IS THAT PEPTIDES WILL BE APPROVED Jonathan Stern: "I have seen a ton of alarmist tweets saying, 'RIP to the peptide bros', essentially. And what you're saying, Ryan, is that it's really not that simple." "We have a process here. We're going to go to PCAC. PCAC is going to make a recommendation to the FDA. But after the PCAC recommendation, the FDA gets to decide. Is that right?" Ryan MacDonald: "Yeah. That's correct... PCAC can make its recommendation and then from there it goes to FDA to make a final decision." "And based on the research that I've done... the final decision goes to the top, goes to the head of the FDA [RFK Jr.]." "It would be surprising to me if there wasn't some sort of involvement from RFK given how vocal he has been." "It's the FDA leadership's domain to make the final decision on this."

Hims House

20,450 Aufrufe • vor 1 Monat

🚨 NEEDHAM ANALYST RYAN MACDONALD: PEPTIDES COULD BE A $30+ BILLION MARKET AND $HIMS IS POSITIONED TO WIN A BIG SHARE This is most thorough deep-dive we've done on the business side of peptides: We discuss the latest peptide news, how the FDA / PCAC process actually works, the size of the peptide opportunity, $HIMS' potential share, the Novo partnership, branded vs compounded economics, short interest, competition, valuation, and more. 🔥 01:58 - FDA briefing document breakdown 04:15 - The timeline of peptide approval 09:50 - Category 1 vs 503A Bulks List 11:34 - When will telehealths start to sell peptides? 14:25 - Sizing the peptide market 19:31 - Hims’ peptide share 21:55 - Peptide pricing & margins 24:45 - Peptides likely a 2027 revenue story 29:58 - Hims-Novo deal check-in 32:11 - Branded vs compounded GLP-1s margins 35:27 - Pills vs injectables 40:43 - International 42:04 - Hims' moat 46:22 - 2030 targets and valuation models 50:32 - Shorts, insiders, and catalysts Not financial, medical, or legal advice

🚨 NEEDHAM ANALYST RYAN MACDONALD: PEPTIDES COULD BE A $30+ BILLION MARKET AND $HIMS IS POSITIONED TO WIN A BIG SHARE This is most thorough deep-dive we've done on the business side of peptides: We discuss the latest peptide news, how the FDA / PCAC process actually works, the size of the peptide opportunity, $HIMS' potential share, the Novo partnership, branded vs compounded economics, short interest, competition, valuation, and more. 🔥 01:58 - FDA briefing document breakdown 04:15 - The timeline of peptide approval 09:50 - Category 1 vs 503A Bulks List 11:34 - When will telehealths start to sell peptides? 14:25 - Sizing the peptide market 19:31 - Hims’ peptide share 21:55 - Peptide pricing & margins 24:45 - Peptides likely a 2027 revenue story 29:58 - Hims-Novo deal check-in 32:11 - Branded vs compounded GLP-1s margins 35:27 - Pills vs injectables 40:43 - International 42:04 - Hims' moat 46:22 - 2030 targets and valuation models 50:32 - Shorts, insiders, and catalysts Not financial, medical, or legal advice

Hims House

85,085 Aufrufe • vor 1 Monat

BPC-157 causing cancer? FDA shutting down peptide trials? “No human RCTs have ever been done on peptides?” In this video, Dr. Alex Tatem — board-certified urologist and fellowship-trained men’s health specialist — reacts to viral claims made on Shawn Ryan Show about BPC-157, TB-500, peptides, angiogenesis, cancer risk, and peptide safety. We break down: • Whether BPC-157 actually causes cancer • The truth about angiogenesis and tumor growth • FDA regulation of peptides and compounding • Why the “no randomized controlled trials” claim is completely false • Human clinical trial data on peptides • The real history of BPC-157 clinical studies • Huberman’s correction of viral peptide misinformation • Why peptide fearmongering could push patients toward unsafe gray-market sourcing This is not bro-science or influencer hype. This is a deep dive into the actual published literature, peptide pharmacology, FDA policy, and performance medicine. Topics covered include: BPC-157, TB-500, peptides, angiogenesis, cancer biology, GLP-1 drugs, Ozempic, tirzepatide, semaglutide, TRT, peptide therapy, biohacking, longevity, anti-aging medicine, compounding pharmacies, peptide legality, Andrew D. Huberman, Ph.D. , Shawn Ryan Show, FDA peptide regulation, growth hormone history, and performance medicine. If you’ve ever wondered whether BPC-157 is dangerous, whether peptides are legal, or whether the internet is fearmongering about peptide therapy — this video is for you.

BPC-157 causing cancer? FDA shutting down peptide trials? “No human RCTs have ever been done on peptides?” In this video, Dr. Alex Tatem — board-certified urologist and fellowship-trained men’s health specialist — reacts to viral claims made on Shawn Ryan Show about BPC-157, TB-500, peptides, angiogenesis, cancer risk, and peptide safety. We break down: • Whether BPC-157 actually causes cancer • The truth about angiogenesis and tumor growth • FDA regulation of peptides and compounding • Why the “no randomized controlled trials” claim is completely false • Human clinical trial data on peptides • The real history of BPC-157 clinical studies • Huberman’s correction of viral peptide misinformation • Why peptide fearmongering could push patients toward unsafe gray-market sourcing This is not bro-science or influencer hype. This is a deep dive into the actual published literature, peptide pharmacology, FDA policy, and performance medicine. Topics covered include: BPC-157, TB-500, peptides, angiogenesis, cancer biology, GLP-1 drugs, Ozempic, tirzepatide, semaglutide, TRT, peptide therapy, biohacking, longevity, anti-aging medicine, compounding pharmacies, peptide legality, Andrew D. Huberman, Ph.D. , Shawn Ryan Show, FDA peptide regulation, growth hormone history, and performance medicine. If you’ve ever wondered whether BPC-157 is dangerous, whether peptides are legal, or whether the internet is fearmongering about peptide therapy — this video is for you.

Dr. Alex Tatem

77,332 Aufrufe • vor 3 Monaten

Hims & Hers Health shares fell over 11% after an FDA advisory panel voted 7 to 6 against adding Emideltide to the compounding 503A Bulks List. THE IMPACT: The narrow rejection raises near-term regulatory hurdles for compounding pharmacy operators looking to offer customized peptide therapies. FUNDAMENTALS: Core operations remain strong, supported by $2.37B in total revenue and a high 72.92% gross margin. THE RATING: Regulatory uncertainty keeps the Seeking Alpha Quant score at a neutral HOLD. Will $HIMS overcome these regulatory hurdles with its expanded pharmacy compounding strategy?

Hims & Hers Health shares fell over 11% after an FDA advisory panel voted 7 to 6 against adding Emideltide to the compounding 503A Bulks List. THE IMPACT: The narrow rejection raises near-term regulatory hurdles for compounding pharmacy operators looking to offer customized peptide therapies. FUNDAMENTALS: Core operations remain strong, supported by $2.37B in total revenue and a high 72.92% gross margin. THE RATING: Regulatory uncertainty keeps the Seeking Alpha Quant score at a neutral HOLD. Will $HIMS overcome these regulatory hurdles with its expanded pharmacy compounding strategy?

Seeking Alpha

10,339 Aufrufe • vor 1 Monat

.Truemed CEO Justin Mares expects FDA guidance on peptides in 2026: "I think that they're going to be incredible tools...It's just gotten too big that the FDA has to do something." "I'm very bullish from an efficacy standpoint. I have tons of questions about quality."

.Truemed CEO Justin Mares expects FDA guidance on peptides in 2026: "I think that they're going to be incredible tools...It's just gotten too big that the FDA has to do something." "I'm very bullish from an efficacy standpoint. I have tons of questions about quality."

TBPN

18,776 Aufrufe • vor 7 Monaten

We asked Jennifer Lin (AUG Tx) about FDA approval for new drugs. AUG Tx gives patients with rare diseases accelerated access to new cures with clear indications of efficacy. "At the end of the day, the FDA is a group of people trying their best to approve drugs that work, and reject drugs with safety issues or are placebos." "For rare diseases, it's easier to get a drug approved as you're often up against placebo or historical controls, because there's usually no approved treatment for these specific diseases." "For popular diseases like cancer, there are already so many drugs that are approved and effective. You have to run really long trials against drugs that work, which are also very expensive."

We asked Jennifer Lin (AUG Tx) about FDA approval for new drugs. AUG Tx gives patients with rare diseases accelerated access to new cures with clear indications of efficacy. "At the end of the day, the FDA is a group of people trying their best to approve drugs that work, and reject drugs with safety issues or are placebos." "For rare diseases, it's easier to get a drug approved as you're often up against placebo or historical controls, because there's usually no approved treatment for these specific diseases." "For popular diseases like cancer, there are already so many drugs that are approved and effective. You have to run really long trials against drugs that work, which are also very expensive."

TBPN

89,205 Aufrufe • vor 1 Jahr

🚨 Emergency Pod 🚨 RFK announces peptide reclassification! what does this all mean? will the technology brothers finally be able to source peptides not of the sketchy chinese kind? is this legalization or a different thing? are the technology brothers going too far with peptides? Max Marchione and i covered all of this and more 00:00 - RFK announce peptide reclassification again 02:31 - Secretary Kennedy reaction 06:18 - What peptides are we likely to see be legalized? 07:41 - Could this affect what peptides are banned or approved by WADA? 08:32 - Are peptides bigger than AI? 09:27 - Do you think it’s a one-off reclassification or will there be a continuous review of peptides from now on? 12:16 - Should I get bloodwork before starting a peptide protocol? 13:27 - What does this mean for Superpower? Will you be the first on the market for peptides? 15:56 - How will you compete with $HIMS? 16:32 - What’s your stack? 18:30 - The tech bros are taking it too far

🚨 Emergency Pod 🚨 RFK announces peptide reclassification! what does this all mean? will the technology brothers finally be able to source peptides not of the sketchy chinese kind? is this legalization or a different thing? are the technology brothers going too far with peptides? Max Marchione and i covered all of this and more 00:00 - RFK announce peptide reclassification again 02:31 - Secretary Kennedy reaction 06:18 - What peptides are we likely to see be legalized? 07:41 - Could this affect what peptides are banned or approved by WADA? 08:32 - Are peptides bigger than AI? 09:27 - Do you think it’s a one-off reclassification or will there be a continuous review of peptides from now on? 12:16 - Should I get bloodwork before starting a peptide protocol? 13:27 - What does this mean for Superpower? Will you be the first on the market for peptides? 15:56 - How will you compete with $HIMS? 16:32 - What’s your stack? 18:30 - The tech bros are taking it too far

atlas

44,226 Aufrufe • vor 4 Monaten

Are peptides safe? Let’s clear this up. Peptides themselves are not the problem. Bad sourcing is. Medical-grade peptides come from certified compounding pharmacies that follow strict USP standards and use raw materials from cGMP-certified manufacturers. That means they are tested for: • purity • sterility • accurate dosing • endotoxins • heavy metals This is what makes them human-grade — designed and tested for actual medical use. Meanwhile, many cheap peptides sold online are research grade. Translation: not meant for human injection. No guarantee of safety. No guarantee of quality. And remember — injections bypass your body’s natural filters. What you inject matters. Peptides are one of the most exciting frontiers in modern medicine — supporting recovery, metabolic health, performance, and longevity. They’re not a trend. They’re a tool. But the rule is simple: Medical supervision. Proper sourcing. Human-grade quality. That’s the difference between optimization… and risk. — Dr. Deano Reyes #PeptideTherapy #LongevityMedicine #RegenerativeMedicine #PerformanceMedicine #DrDeanoReyes #HaraClinic

Are peptides safe? Let’s clear this up. Peptides themselves are not the problem. Bad sourcing is. Medical-grade peptides come from certified compounding pharmacies that follow strict USP standards and use raw materials from cGMP-certified manufacturers. That means they are tested for: • purity • sterility • accurate dosing • endotoxins • heavy metals This is what makes them human-grade — designed and tested for actual medical use. Meanwhile, many cheap peptides sold online are research grade. Translation: not meant for human injection. No guarantee of safety. No guarantee of quality. And remember — injections bypass your body’s natural filters. What you inject matters. Peptides are one of the most exciting frontiers in modern medicine — supporting recovery, metabolic health, performance, and longevity. They’re not a trend. They’re a tool. But the rule is simple: Medical supervision. Proper sourcing. Human-grade quality. That’s the difference between optimization… and risk. — Dr. Deano Reyes #PeptideTherapy #LongevityMedicine #RegenerativeMedicine #PerformanceMedicine #DrDeanoReyes #HaraClinic

Dr. Deano

14,259 Aufrufe • vor 6 Monaten

"We should do what the FDA has said they're doing: legalize several of the category 2 peptides that have the strongest safety and efficacy signals." — Max Marchione "Because that reduces net harm for patients and increases net benefit, even if pharma doesn't like it because they're not making money from their $100,000 biologic drug anymore." "When new data and new science come along, and there's a dangerous gray market, we need to accept that the times have changed and adapt the regulation."

"We should do what the FDA has said they're doing: legalize several of the category 2 peptides that have the strongest safety and efficacy signals." — Max Marchione "Because that reduces net harm for patients and increases net benefit, even if pharma doesn't like it because they're not making money from their $100,000 biologic drug anymore." "When new data and new science come along, and there's a dangerous gray market, we need to accept that the times have changed and adapt the regulation."

TBPN

14,300 Aufrufe • vor 5 Monaten

Louisa Nicola says peptides are too risky to take. Not one peptide on the gray market has been through a human safety trial. Zero. BPC-157 is not FDA approved. The FDA blocked compounding pharmacies from using it because of insufficient safety data Yet people are buying it on the black market and injecting it anyway. She also says it also new blood vessels in your body and so do cancer cells. It could potentially help cancer cells grow. In her words: "The same people that are scared of vaccines are the ones buying peptides on the gray market. Make it make sense." You don't know what's in the bottle. You don't know what it's doing to your body. — Louisa Nicola (Louisa Nicola) on the Shawn Ryan’s (Shawn Ryan Show) podcast

Louisa Nicola says peptides are too risky to take. Not one peptide on the gray market has been through a human safety trial. Zero. BPC-157 is not FDA approved. The FDA blocked compounding pharmacies from using it because of insufficient safety data Yet people are buying it on the black market and injecting it anyway. She also says it also new blood vessels in your body and so do cancer cells. It could potentially help cancer cells grow. In her words: "The same people that are scared of vaccines are the ones buying peptides on the gray market. Make it make sense." You don't know what's in the bottle. You don't know what it's doing to your body. — Louisa Nicola (Louisa Nicola) on the Shawn Ryan’s (Shawn Ryan Show) podcast

Goku

39,600 Aufrufe • vor 4 Monaten